Komal Joshi | Investor Relations |
Rich Murray | President and Chief Executive Officer |
Beth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Boris Peaker | Cowen |
James Birchenough | Wells Fargo |
Mike Ulz | Robert W. Baird |
Debjit Chattopadhyay | H.C. Wainwright |
Steven Seedhouse | Raymond James |
Good morning, ladies and gentlemen and welcome to the Jounce Therapeutics Fourth Quarter and Full Year 2018 Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded at the company’s request. I will now turn the call over to your host, Komal Joshi with Jounce Therapeutics.